Search Results - "Gaillard, Pieter J"

Refine Results
  1. 1
  2. 2

    Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation by Gaillard, Pieter J., Appeldoorn, Chantal C.M., Rip, Jaap, Dorland, Rick, van der Pol, Susanne M.A., Kooij, Gijs, de Vries, Helga E., Reijerkerk, Arie

    Published in Journal of controlled release (28-12-2012)
    “…Neuroinflammation contributes to a wide range of disorders of the central nervous system (CNS). Of the available anti-inflammatory drugs, only glucocorticoids…”
    Get full text
    Journal Article
  3. 3

    Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats by Rip, Jaap, Chen, Linda, Hartman, Robin, van den Heuvel, Angelique, Reijerkerk, Arie, van Kregten, Joan, van der Boom, Burt, Appeldoorn, Chantal, de Boer, Marco, Maussang, David, de Lange, Elizabeth C. M., Gaillard, Pieter J.

    Published in Journal of drug targeting (01-06-2014)
    “…Abstract Partly due to poor blood-brain barrier drug penetration the treatment options for many brain diseases are limited. To safely enhance drug delivery to…”
    Get full text
    Journal Article
  4. 4

    A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes by Wisniewska-Kruk, Joanna, Hoeben, Kees A., Vogels, Ilse M.C., Gaillard, Pieter J., Van Noorden, Cornelis J.F., Schlingemann, Reinier O., Klaassen, Ingeborg

    Published in Experimental eye research (01-03-2012)
    “…Loss of blood-retinal barrier (BRB) properties is an important feature in the pathology of diabetic macular edema (DME), but cellular mechanisms underlying BRB…”
    Get full text
    Journal Article
  5. 5

    Targeted blood-to-brain drug delivery --10 key development criteria by Gaillard, Pieter J, Visser, Corine C, Appeldoorn, Chantal C M, Rip, Jaap

    Published in Current pharmaceutical biotechnology (01-09-2012)
    “…Drug delivery to the brain remains challenging due to the presence of the blood-brain barrier. In this review, 10 key development criteria are presented that…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Treatment with penicillin G and hydrocortisone reduces ALS-associated symptoms: a case series of three patients by Tuk, Bert, Jousma, Harmen, Gaillard, Pieter J

    Published in F1000 research (2017)
    “…Three male Caucasian patients with ALS were admitted to the hospital due to progressive dysphagia and dysarthria. During two 21-day courses of penicillin G and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference? by Hu, Yang, Gaillard, Pieter J., de Lange, Elizabeth C.M., Hammarlund-Udenaes, Margareta

    “…[Display omitted] The purpose of this study was to quantitatively investigate how conjugation of GSH to different liposomal formulations influence the brain…”
    Get full text
    Journal Article
  11. 11
  12. 12

    In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes by Lindqvist, Annika, Rip, Jaap, van Kregten, Joan, Gaillard, Pieter J, Hammarlund-Udenaes, Margareta

    Published in Pharmaceutical research (01-01-2016)
    “…Purpose The purpose of this study was to evaluate formulation factors causing improvement in brain delivery of a small peptide after encapsulation into a…”
    Get full text
    Journal Article
  13. 13

    Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma by Höbel, Sabrina, Appeldoorn, Chantal C M, Gaillard, Pieter J, Aigner, Achim

    Published in Pharmaceuticals (Basel, Switzerland) (16-12-2011)
    “…RNA interference (RNAi) allows the specific knockdown of tumor relevant genes. To induce RNAi, the delivery of small interfering RNAs (siRNAs) is of crucial…”
    Get full text
    Journal Article
  14. 14

    The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study by Hu, Yang, Rip, Jaap, Gaillard, Pieter J, de Lange, Elizabeth C M, Hammarlund-Udenaes, Margareta

    Published in Journal of pharmaceutical sciences (01-09-2017)
    “…The impact of liposomal formulations on the in vivo release and brain delivery of methotrexate (MTX) was quantitatively assessed in rats. Two PEGylated…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Enhanced Brain Delivery of the Opioid Peptide DAMGO in Glutathione PEGylated Liposomes: A Microdialysis Study by Lindqvist, Annika, Rip, Jaap, Gaillard, Pieter J, Björkman, Sven, Hammarlund-Udenaes, Margareta

    Published in Molecular pharmaceutics (06-05-2013)
    “…Glutathione PEGylated (GSH-PEG) liposomes were evaluated for their ability to enhance and prolong blood-to-brain drug delivery of the opioid peptide DAMGO…”
    Get full text
    Journal Article
  17. 17

    In Vivo Quantitative Understanding of PEGylated Liposome’s Influence on Brain Delivery of Diphenhydramine by Hu, Yang, Gaillard, Pieter J., Rip, Jaap, de Lange, Elizabeth C.M., Hammarlund-Udenaes, Margareta

    Published in Molecular pharmaceutics (03-12-2018)
    “…Despite the promising features of liposomes as brain drug delivery vehicles, it remains uncertain how they influence the brain uptake in vivo. In order to gain…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Strategies to improve drug delivery across the blood-brain barrier by DE BOER, Albertus G, GAILLARD, Pieter J

    Published in Clinical pharmacokinetics (01-01-2007)
    “…The blood-brain barrier (BBB), together with the blood-cerebrospinal-fluid barrier, protects and regulates the homeostasis of the brain. However, these…”
    Get full text
    Journal Article